Mainstream Capital Management
RGC icon

Mainstream Capital Management’s Regencell Bioscience RGC Stock Holding History

Mainstream Capital Management’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$62 Buy
+10
New +$58 ﹤0.01% 298

Mainstream Capital Management's RGC Position: Q3 2026 in Review

Mainstream Capital Management opened a new position in Regencell Bioscience (RGC) in Q3 2026: 10 shares worth $62. The stake represents ﹤0.01% of the portfolio and ranks #298 among its holdings.

1 fund tracked by Wall St. Rank holds RGC as of Q3 2026.

  • Mainstream Capital Management held 10 shares of Regencell Bioscience worth $62 as of Q3 2026.
  • Regencell Bioscience was a new Mainstream Capital Management position in Q3 2026.
  • Regencell Bioscience made up ﹤0.01% of Mainstream Capital Management's portfolio in Q3 2026, its #298 holding.
  • 1 fund tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on Mainstream Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.